| abstract |
This invention provides an effective and safe medication for the treatment of diseases of the connective tissue of the skin, in particular with regard to the treatment of cutaneous lupus erythematosus. As therapeutically active ingredient, medicaments include R-salbutamol or a pharmaceutically acceptable salt thereof. Moreover, the invention relates to dermatological compositions in the absence of sensitizing properties of the skin, which contain R-salbutamol or its pharmaceutically acceptable salt. |